Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol tartrate inhalation solution for COPD
CTR20243058Phase 3Active
- Sponsor
- Hainan Sida Pharmaceutical
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arformoterol in chronic obstructive pulmonary disease (COPD), sponsored by Hainan Sida Pharmaceutical. Started Dec 2024; status: active.
02
Drugs
arformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20243058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243058.